Care Ratings reaffirms CD rating of IndusInd Bank at 'A1+'
Care Ratings stated that the reaffirmation of the rating assigned to the certificate of deposit (CD) programme of IndusInd Bank Limited (IBL) factors in comfortable capitalisation levels and growing franchise of the bank with focus on retail lending, earning higher yield on advances.
While IBL has historically maintained a healthy earnings track record, profitability moderated in 9MFY25 due to elevated credit costs and a rise in deposit rates. CARE Ratings expects earnings in Q4FY25 to remain subdued due to one-time adjustments from derivative accounting discrepancies and potential implications arising from the ongoing review of the microfinance (MFI) portfolio.
The rating also considers IBLs moderate resource profile, which has relatively higher proportion of bulk deposits. Asset quality moderated considering ongoing industry related stress in microfinance segment, which contributed 9% to the advances as on 31 December 2024 (down from 11% as on March 31, 2024) resulting in an increase in gross non-performing assets (GNPA) to 2.25% from 1.92% over the same period.
CARE Ratings takes note of the lapses in the internal financial controls following the derivative accounting discrepancies identified in FY25, which will also adversely impact its earnings in Q4FY25.
With resignations of both the managing director & CEO and the deputy CEO in April 2025, the progress of management transition, succession and stabilisation of operations will remain a key monitorable, notwithstanding the setting up of a committee of executives to manage day-to-day operations under the supervision of a board-level oversight committee until a new MD & CEO is appointed.
Per the banks disclosure on 22 April 2025, the bank has roped in Ernst and Young (E&Y) to assist its internal audit department to examine certain concerns in the microfinance business, which have been brought to its attention in finalisation of accounts.
Any adverse outcome in this matter can affect IBLs profitability and hence would remain an additional monitorable.
Indusind Bank (IBL) is a new-generation private-sector bank promoted by the Hinduja group. IBL is the fifth-largest private bank in India in terms of total assets and total business as on 31 December 2024. The bank has a pan-India presence with 2,984 bank branches, 3772 branches of its wholly owned subsidiary BFIL, 300 vehicle finance marketing outlets, and 2,993 ATMs as on 31 December 2024. It also has representative offices in Dubai, Abu Dhabi, and London.
The scrip had gained 0.26% to end at Rs 782.30 on the BSE on Friday.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
a minute ago
- Business Standard
Shanti Gold IPO Day 2 update: Subscription surpasses 3x, GMP at 19%
Shanti Gold International IPO subscription status: The initial public offering (IPO) of Shanti Gold International, which opened for public subscription on Friday, July 25, has received a favourable response from investors. The NSE data suggests that the ₹360 crore offering of Shanti Gold International received bids for 3,92,51,625 shares, against 1,26,67,200 shares on offer, resulting in a subscription of 3.10 times as of 1:06 PM on Monday, July 28. Among the investor categories, retail investors led the demand by oversubscribing the category reserved for them by 4.57 times. This was followed by non-institutional investors (NIIs), who bid for 3.77 times, and qualified institutional buyers (QIBs), for 0.02 times. Shanti Gold International IPO details The public offering is a book-built issue, which comprises an entirely fresh issue of 18.1 million equity shares worth ₹360.11 crore. Shanti Gold International IPO is available at a price band of ₹189-199 per share, and a lot size of 75 shares. Thus, investors can bid for a minimum of 75 shares of Shanti Gold International IPO and in multiples thereof. To bid for one lot or 75 shares of Shanti Gold International IPO, a retail investor would require a minimum of ₹14,925, taking the upper end of the IPO price into consideration. A retail investor can bid for a maximum of 13 lots or 975 shares, amounting to ₹1,94,025. Shanti Gold International IPO grey market premium (GMP) The unlisted shares of Shanti Gold International were commanding a decent premium in the grey market on the second day of its subscription window. Sources tracking unofficial market activities revealed that Shanti Gold International shares were seen trading at around ₹237 per share, reflecting a grey market premium (GMP) of ₹38 or 19.10 per cent over the upper end of the issue price. Shanti Gold International IPO review The company has received favourable reviews from the brokerages for its public offering. Analysts at Arihant Capital have recommended the investors to subscribe to the Shanti Gold International IPO, while those at Anand Rathi Research Team have recommended subscribing to the issue for a long-term perspective. READ MORE Shanti Gold International IPO allotment date, listing date The three-day subscription window to bid for the public offering is set to conclude on Tuesday, July 29, 2025. Following the closure of the subscription window, the basis of allotment of Shanti Gold International IPO shares is likely to get finalised on Wednesday, July 30, 2025, with shares getting credited into demat accounts by Thursday, July 31, 2025. Shares of Shanti Gold International are set to make their D-Street debut on Friday, August 1, 2025, by listing on the BSE and NSE. Shanti Gold International IPO objective The company intends to utilise the proceeds from the public issue towards funding capital expenditure requirements for setting up the proposed Jaipur facility, as well as funding the working capital requirements of the company. The company will further use the IPO proceeds for repayment and/or pre-payment, in full or part, of certain borrowings availed, as well as for general corporate purposes. Shanti Gold International IPO registrar, lead managers For the public offering, Bigshare Services serves as the registrar, while Choice Capital Advisors is the sole book-running lead manager. About Shanti Gold International Incorporated in 2003, Shanti Gold International manufactures high-quality 22kt CZ casting gold jewelry with a focus on design and production. The company has an in-house manufacturing setup and uses advanced machines and CAD technology to create intricate pieces. With a 13,448.86 sq ft manufacturing facility in Mumbai, Shanti Gold produces a wide range of jewelry, including bangles, rings, and necklaces. The company has established relationships with several jewelry businesses and operates in 15 states and one union territory.
&w=3840&q=100)
Business Standard
a minute ago
- Business Standard
Vijay Kedia portfolio stock soars 12% in subdued market. Do you own?
Shares of Sudarshan Chemical hit a new high of ₹1,395.20, soaring 12% on the BSE in Monday's intra-day trade and bouncing back 75% from its 52-week low price of ₹795.75 touched on March 3, 2025. Share price of Sudarshan Chemical Industries today Shares of Sudarshan Chemical Industries hit a new high of ₹1,395.20, soaring 12 per cent on the BSE in Monday's intra-day trade in an otherwise weak market. The stock price of the smallcap dyes and pigments company surpassed its previous high of ₹1,313.95 hit on July 2, 2025. It has zoomed 75 per cent from its 52-week low of ₹795.75 touched on March 3, 2025. At 11:44 AM; Sudarshan Chemical Industries was trading 11 per cent higher at ₹1,391.95, as compared to 0.23 per cent decline in the BSE Sensex. A combined 2.1 million equity shares changed hands on the NSE and BSE. Vijay Kishanlal Kedia held over 1% stake in Sudarshan Chemical Industries Ace investor Vijay Kishanlal Kedia held 1 million equity shares or 1.27 per cent stake in Sudarshan Chemical Industries at the end of June 30, 2025 quarter, the shareholding pattern data shows. Besides Vijay Kedia, Akash Bhanshali (7.13 per cent), Anuj Narayandas Rathi (6.93 per cent), Vijaykumar Ramchandra Rathi (2.66 per cent stake), Rohit Kishor Rathi (2.62 per cent) and Lata Bhanshali (1.46 per cent) hold more than 1 per cent stake in Sudarshan Chemical Industries, data shows. Q4FY25 results - Sudarshan Chemical Industries For the January to March 2025 quarter (Q4FY25), Sudarshan Chemical Industries reported revenues of ₹1,349 crore, up 78 per cent year-on-year (YoY) driven by Heubach acquisition. The company reported profit before exceptional items of ₹69.34 crore, against ₹78.02 crore in a year ago quarter and of ₹ 35.52 crore in December 2024 quarter. The numbers are not comparable as base adjustment is yet to take place. Financial results including financial ratios for the quarter and year ended March 31, 2025 include the impact of the above transaction w.e.f. March 3, 2025 and are thus not comparable with corresponding previous periods, the company said in note of accounts. Sudarshan Chemical Industries in an exchange filing said, the company host a conference call for analysts and investors on Tuesday, 29th July, 2025 at 12:00 pm (IST), following the announcement of the audited financial results (stand-alone and consolidated) for the quarter and year ended March 31, 2025. Reasons for delay in Q4 results Sudarshan Chemical Industries entered into a definitive agreement on October 11, 2024, through its wholly-owned subsidiary Sudarshan Europe B.V., the Netherlands (SEBV), to acquire the Global Pigment Business Operations of the Heubach Group of Germany (Heubach Group) on a debt-free basis for a total consideration of EURO 127.5 million (approximately ₹1,180 crore). Pursuant to the acquisition, the company has acquired and taken control of 50 direct and step-down subsidiaries and 17 manufacturing sites from Heubach Group across various geographies across the globe. The company is required to submit audited financial results for FY 2024-25, including the newly acquired subsidiaries, by May 30, 2025. However, because of the insolvency impact, extensive financial reporting integration, complexities involved in business combination accounting, the company said it would not be able to meet the deadline. The acquisition will help Sudharshan emerge as a leading global pigment company with a presence across 19 countries, as well as 17 manufacturing facilities in 11 countries. The Heubach group is the second largest player in the global pigment sector and is estimated to have reported revenues of close to around EURO 800 million.
&w=3840&q=100)
Business Standard
a minute ago
- Business Standard
Acme Solar Holdings shares jump 10% post Q1 earnings; check details
Acme Solar Holdings share price today: Shares of renewable energy firm, Acme Solar Holdings, surged 10 per cent on Monday, July 28, 2025, hitting an intraday high of ₹297.48. At 11:35 AM, Acme Solar Holdings shares were trading at ₹293.90, up by 8.75 per cent on the BSE. In comparison, BSE Sensex was trading largely flat, albeit with a negative bias, down by 92 points or 0.11 per cent, quoting 81,370.50. The total market capitalisation of the company stood at ₹17,772.03 crore. The buying interest on the counter came after the company released its earnings for the first quarter of the financial year 2025-2026 (Q1FY26). Acme Solar Holdings Q1FY26 earnings The renewable energy solutions provider reported a 71 per cent surge in revenue from operations to ₹584 crore in Q1FY26, as against ₹340 crore reported in the corresponding quarter of the previous fiscal year. The company's profit after tax (PAT) experienced a robust rise to ₹131 crore in Q1FY26 from just ₹1 crore recorded in the first quarter of FY25. Earnings before interest, taxes, depreciation and amortisation (Ebitda) also rose by 75.7 per cent to ₹531 crore during the quarter under review from ₹302 crore recorded in Q1FY25. Ebitda margins stood at 90.9 per cent during the June quarter. As per brokerage firm JM Financial, the rise in company profits was mainly due to an increase in other income by ₹42.6 crore annually. Meanwhile, PAT margins for the quarter stood at 22.4 per cent as against 0.4 per cent reported in the same period of the last fiscal year. During the June quarter, the company commissioned 250 megawatt (MW) projects, including a 50 MW wind project in Gujarat. As per the exchange filing, this takes Acme Solar's overall operational portfolio to 2,890 MW, indicating a rise of 115.7 per cent on a year-on-year (Y-o-Y) basis. Check List of Q1 results today Brokerage View- Religare Broking On Monday, the stock started the day with a gap-up opening of nearly 6 per cent and extended the gains to 10 per cent in just a single trading session. "Acme solar holdings has been trading on bullish scenario with positive numbers in Q1FY26 with total revenue growing nearly 72 per cent. ACME did really well this quarter, especially in terms of orderbook," said Ravi Singh, SVP-retail research, Religare Broking. However, Singh advised investors to take a 'Buy' stance within the ₹280-₹285 range, signalling a prospective upside of 14.2 per cent. "On technical charts, stock price has given a bullish breakout from the ₹252 level at the start of July month. With the current outlook, the stock is likely to build bullish momentum in the coming sessions and recommend a 'Buy' position within ₹280-₹285 for the upside targets of ₹320 with risk managed at ₹270," he added.
